Michelson Medical Research Foundation Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DigitalBridge
DBRG
|
+$5.81M |
| 2 |
SAFE
Safehold
SAFE
|
+$4.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$12.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$8.42M |
| 3 |
Prologis
PLD
|
+$3.14M |
| 4 |
Burford Capital
BUR
|
+$2.38M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 12.97% |
| 2 | Industrials | 10.54% |
| 3 | Financials | 6.05% |
| 4 | Real Estate | 4.44% |
| 5 | Communication Services | 3.42% |
Similar funds
Michelson Medical Research Foundation's Q2 2025 Portfolio in Review
As of Q2 2025, Michelson Medical Research Foundation held 27 positions worth $104M, down 13% from $120M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Michelson Medical Research Foundation withdrew a net $22M in Q2 2025, closing 7 positions and reducing 3 holdings. Its most notable exit was iShares S&P Small-Cap 600 Value ETF, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.
Against the trend, Michelson Medical Research Foundation opened a new position in DigitalBridge worth $6.31M.
- Michelson Medical Research Foundation's largest Q2 2025 buy was DigitalBridge: 609,500 shares worth $6.31M.
- Michelson Medical Research Foundation's biggest Q2 2025 reduction was iShares Biotechnology ETF, cutting an estimated $1.02M.
- Michelson Medical Research Foundation fully exited iShares S&P Small-Cap 600 Value ETF in Q2 2025, selling an estimated $12.7M.
- Michelson Medical Research Foundation's ten largest holdings make up 79% of its $104M portfolio in Q2 2025.
- Michelson Medical Research Foundation opened 2 new positions and closed 7 in Q2 2025.
- Michelson Medical Research Foundation's portfolio value fell 13% quarter-over-quarter to $104M.
Based on Michelson Medical Research Foundation's 13F filing for Q2 2025, filed 14 Aug 2025.